In human pregnancy, the transport of antibodies ... has changed from fetal blood transfusion to maternal therapy with anti-D IgG. The therapy with anti-D IgG has brought major successes associated ...

James Harrison’s legacy is at the heart of a wild story about canny science, boundless goodwill and an errant blood ...

Immunome's strong financial position supports ongoing clinical development and potential market entry for key assets. See why ...

The U.S. Food and Drug Administration has approved a self-injection version of Vyvgart Hytrulo (efgartigimod alfa and ...

For one, microglia hovering around plaques—the type that express the most TREM2—reportedly become desensitized to stimulation ...

Absci gained on animal testing phaseout news, but the change has limited near-term impact on its investment case. Read why ...

REDWOOD CITY, CA, USA I April 14, 2025 I Pheast Therapeutics, a private biotechnology company developing novel therapies to unleash the power of macrophages ...

Henlius (2696) held its 2025 Global R&D Day under the theme of "Collaborate to Create". Senior executives from Henlius gathered with leading experts, scholars, and heads of innovation from across the ...

In the European Union (EU), lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment and mild ...

Paris: Sanofi has received approval from the US Food and Drug Administration (FDA) for Dupixent (dupilumab) for the treatment ...

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than ...